Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Phathom Pharmaceuticals, Inc. (PHAT) had Debt to Capital Ratio of -0.94 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$58.30M |
|
$-30.37M |
|
$12.00M |
|
$46.30M |
|
$73.78M |
|
$-15.48M |
|
$-14.89M |
|
$-30.37M |
|
$-30.37M |
|
$-30.37M |
|
$-30.37M |
|
$-30.37M |
|
$-30.37M |
|
$-15.48M |
|
$-14.52M |
|
82.05M |
|
82.05M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$276.57M |
|
$1.02M |
|
$28.55M |
|
$305.12M |
|
$125.04M |
|
$163.68M |
|
$517.03M |
|
$642.08M |
|
$-336.95M |
|
$-336.95M |
|
$-336.95M |
|
79.44M |
|
| Cash Flow Statement Financials | |
$-15.65M |
|
$-0.06M |
|
$66.64M |
|
$132.83M |
|
$183.76M |
|
$50.93M |
|
$5.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.21 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-0.94 |
-0.49 |
|
79.42% |
|
-26.55% |
|
-26.55% |
|
-- |
|
-52.09% |
|
-52.09% |
|
$-15.71M |
|
-- |
|
-- |
|
-- |
|
0.19 |
|
1.84 |
|
0.72 |
|
124.61 |
|
9.01% |
|
9.01% |
|
-9.95% |
|
17.53% |
|
$-4.24 |
|
$-0.19 |
|
$-0.19 |
|